Dr Reddys Laboratories (RDY) Assets Average (2009 - 2026)
Dr Reddys Laboratories (RDY) posted Assets Average of $6.2 billion for Q2 2026, down 1.93% on a QoQ basis from $6.3 billion in Q1 2026, and up 5.53% year-over-year from $5.9 billion in Q2 2025.
Analysis
Dr Reddys Laboratories (RDY) Assets Average (2009 - 2026) Analysis & Trends
Dr Reddys Laboratories has reported Assets Average for 17 years, with the latest figure at $6.2 billion in Q2 2026.
- On a quarterly basis, Assets Average rose 5.53% year-over-year to $6.2 billion in Q2 2026; TTM through Jun 2026 was $6.2 billion, a 5.53% increase from a year earlier, with the FY2026 full-year figure at $6.0 billion, up 14.63% from the prior year.
- Assets Average was $6.2 billion for Q2 2026 at Dr Reddys Laboratories, down from $6.3 billion in the prior quarter.
- The five-year high for Assets Average was $6.3 billion in Q1 2026, with the low at $3.7 billion in Q4 2022.
- Average Assets Average over 5 years is $4.9 billion, with a median of $4.7 billion recorded in 2024.
- The sharpest annual moves came in 2022 and 2024: Assets Average fell 1.49% in 2022, then advanced 29.8% in 2024.
- Over 5 years, Assets Average stood at $3.7 billion in 2022, then advanced by 16.97% to $4.3 billion in 2023, then rose by 29.8% to $5.6 billion in 2024, then increased by 11.32% to $6.3 billion in 2025, then retreated by 0.96% to $6.2 billion in 2026.
- The last three Assets Average figures came in at $6.2 billion (Q2 2026), $6.3 billion (Q1 2026), and $6.3 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | 39.95 Bn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | 35.94 Bn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | 6.21 Bn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | 3.66 Bn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | 24.65 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | 1.50 Bn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 1.46 Bn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | 1.70 Bn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | 73.15 Mn |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | 21.86 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.21 Bn |
| Mar 31, 2026 | 6.33 Bn |
| Dec 31, 2025 | 6.27 Bn |
| Sep 30, 2025 | 6.14 Bn |
| Jun 30, 2025 | 5.88 Bn |
| Mar 31, 2025 | 5.70 Bn |
| Dec 31, 2024 | 5.63 Bn |
| Sep 30, 2024 | 5.27 Bn |
| Jun 30, 2024 | 4.82 Bn |
| Mar 31, 2024 | 4.57 Bn |
| Dec 31, 2023 | 4.34 Bn |
| Sep 30, 2023 | 4.14 Bn |
| Jun 30, 2023 | 4.00 Bn |
| Mar 31, 2023 | 3.84 Bn |
| Dec 31, 2022 | 3.71 Bn |
| Sep 30, 2022 | 3.74 Bn |
| Jun 30, 2022 | 3.87 Bn |
| Mar 31, 2022 | 3.83 Bn |
| Dec 31, 2021 | 3.76 Bn |
| Sep 30, 2021 | 3.77 Bn |